CeriBell, Inc. Stock-Based Compensation
CeriBell, Inc. (CBLL) reported Stock-Based Compensation of $9.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- CeriBell, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $6.00M, a 89.39% increase year-over-year.
- CeriBell, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $3.72M, a 58.56% increase year-over-year.
- CeriBell, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $3.36M, a 52.54% increase year-over-year.
- CeriBell, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.35M, a 143.39% increase year-over-year.
- CeriBell, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $12.22M, a 125.89% increase from fiscal 2024.
- CeriBell, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $5.41M, a 102.05% increase from fiscal 2023.
- CeriBell, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $2.68M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $9.72M 10-Q · filed 2026-08-10 | $13.08M derived: sum of 3 quarters · filed 2026-08-10 | $16.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $3.72M 10-Q · filed 2026-05-11 | $7.08M derived: sum of 2 quarters · filed 2026-05-11 | $10.43M derived: sum of 3 quarters · filed 2026-05-11 | $13.60M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.71M derived: sum of 2 quarters · filed 2026-02-24 | $9.88M derived: sum of 3 quarters · filed 2026-08-10 | $12.22M 10-K · filed 2026-02-24 |
| 2025-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.52M derived: sum of 2 quarters · filed 2026-08-10 | $8.86M 10-Q · filed 2025-11-04 | $11.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $3.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.51M 10-Q · filed 2026-08-10 | $7.72M derived: sum of 3 quarters · filed 2026-08-10 | $9.09M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.35M 10-Q · filed 2026-05-11 | $4.55M derived: sum of 2 quarters · filed 2026-05-11 | $5.93M derived: sum of 3 quarters · filed 2026-05-11 | $7.00M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.58M derived: sum of 2 quarters · filed 2026-02-24 | $4.65M derived: sum of 3 quarters · filed 2026-02-24 | $5.41M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.45M derived: sum of 2 quarters · filed 2025-11-04 | $3.21M 10-Q · filed 2025-11-04 | $3.95M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.83M 10-Q · filed 2025-08-05 | $2.58M derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $757.00K 10-Q · filed 2025-05-08 | $1.50M derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $745.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.68M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $1.93M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |